Question 1

What is Myriad Genetics?

Accepted Answer

Myriad Genetics is a Company.

Question 2

How often does Myriad Genetics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Myriad Genetics first tracked by Ergen?

Accepted Answer

First tracked on May 26, 2026.

Question 4

When was Myriad Genetics last mentioned in news?

Accepted Answer

Last active on Jul 02, 2026.

Question 5

What is Myriad Genetics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Myriad Genetics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Myriad Genetics?

Accepted Answer

Myriad Prolaris Test Data Published (Jul 02, 2026, 6 articles).

Question 8

How did the "Myriad Prolaris Test Data Published" event impact Myriad Genetics?

Accepted Answer

Myriad Genetics announced new data from a meta-analysis demonstrating the significant prognostic value of its Prolaris Biopsy Test for localized prostate cancer, which is expected to enhance the test's adoption and market position.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.